Express Scripts 2013 Annual Report Download - page 21

Download and view the complete annual report

Please find page 21 of the 2013 Express Scripts annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 124

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124

21 Express Scripts 2013 Annual Report
Forward-Looking Statements and Associated Risks
Information we have included or incorporated by reference in this Annual Report on Form 10-K, and information
which may be contained in our other filings with the Securities and Exchange Commission (“the SEC”) and our press releases
or other public statements, contains or may contain forward-looking statements. These forward-looking statements include,
among others, statements of our plans, objectives, expectations (financial or otherwise) or intentions.
Our forward-looking statements involve risks and uncertainties. Our actual results may differ significantly from
those projected or suggested in any forward-looking statements. We do not undertake any obligation to release publicly any
revisions to such forward-looking statements to reflect events or circumstances occurring after the date hereof or to reflect the
occurrence of unanticipated events. Any number of factors could cause our actual results to differ materially from those
contemplated by any forward-looking statements, including, but not limited to, the risks associated with the following:
STANDARD OPERATING FACTORS
• our ability to remain profitable in a very competitive marketplace depends upon our continued ability to
attract and retain clients while maintaining our margins, to differentiate our products and services from those
of our competitors, and to develop and cross-sell new products and services to our existing clients
• our failure to anticipate and appropriately adapt to changes or trends within the rapidly changing healthcare
industry
• changes in applicable laws, rules or regulations, or their interpretation or enforcement, or the enactment of
new laws, rules or regulations, which apply to our business practices (past, present or future) or require us to
spend significant resources in order to comply or to make significant changes to our business operations
• changes to the healthcare industry designed to manage healthcare costs or alter healthcare financing
practices or changes to government policies in general
• uncertainties regarding the implementation of Health Reform Laws
• general economic conditions
• a failure in the security or stability of our technology infrastructure, or the infrastructure of one or more of our
key vendors, or a significant failure or disruption in service within our operations or the operations of such
vendors
• our failure to execute on, or other issues arising under, certain key client contracts
• significant changes within the pharmacy provider marketplace, including the loss of or adverse change in our
relationship with one or more key pharmacy providers
• changes relating to our participation in Medicare Part D, the loss of Medicare Part D eligible members, or
our failure to otherwise execute on our strategies related to Medicare Part D
• our failure to effectively execute on strategic transactions or successfully integrate the business operations or
achieve the anticipated benefits from any acquired businesses
• a failure to adequately protect confidential health information received and used in our business operations
• uncertainty around realization of the anticipated benefits of the transaction with Medco, including the
expected amount and timing of cost savings and operating synergies or difficulty in integrating the businesses
of Express Scripts, Inc. and Medco or in retaining clients of the respective companies
• the impact of our debt service obligations on the availability of funds for other business purposes, and the
terms of and our required compliance with covenants relating to our indebtedness
• the delay, reduction, suspension or cancellation of government spending or appropriations relating to our
business
• the termination, loss, or an unfavorable modification, of our relationship with one or more key pharmaceutical
manufacturers, or the significant reduction in payments made or discounts provided by pharmaceutical
manufacturers
• changes in industry pricing benchmarks